UCSD launches bacteriophage treatment center

The University of California San Diego launched the Center for Innovative Phage Applications and Therapeutics (IPATH) to develop bacteriophages to fight multidrug-resistant bacteria. The initial focus will be on treating chronic infections associated with cystic fibrosis, organ transplantation and implantable hardware. The center hopes to start clinical trials by year end.

The university said IPATH is the first bacteriophage treatment center in North America...